Roche and Novartis Stocks Surge as Trump Drug Plan Unveiled December

Today, President Donald Trump’s announcement of an agreement with major drugmakers, including Roche and Novartis, has stirred excitement in the stock market. The initiative aims to tackle high drug prices, drawing significant investor attention. As a result, shares of Roche ROG.SW and Novartis NVS have surged, making headlines in Switzerland and beyond.